Navigation Links
Roche Extends Tender Offer for Ventana
Date:8/21/2007

BASEL, Switzerland, Aug. 21 /PRNewswire/ -- Roche (SWX: ROG.VX; RO.S), a world-leading healthcare provider of pharmaceuticals and diagnostics, announced today that it has extended its offer to acquire all of the outstanding common shares of Ventana Medical Systems, Inc. (Nasdaq: VMSI) to 5:00 p.m., New York City time on Thursday, September 20, 2007. The tender offer was previously scheduled to expire at 5:00 p.m., New York City time, on August 23, 2007. All other terms and conditions of the tender offer remain unchanged. As of the close of business on August 21, 2007, approximately 13,430 shares have been tendered pursuant to the offer.

On June 27, 2007, Roche commenced a tender offer to acquire all of the outstanding common shares of Ventana for $75.00 per share in cash. This price represents a 44% premium to Ventana's close of $51.95 on June 22, 2007 (the last trading day prior to the announcement of Roche's offer) and a 55% premium to its three-month average as of the same date of $48.30.

Greenhill & Co. and Citi are acting as financial advisors to Roche and Davis Polk & Wardwell is acting as legal counsel.

About Roche

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as
'/>"/>

SOURCE Roche
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Advantages of Roche Applied Science amplification products
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. NimbleGen to discontinue IPO after Roches $272.5 million acquisition
5. Prodesse enters patent agreement with Roche
6. NimbleGen extends research market reach
7. TomoTherapy extends reach to Germany
8. Third Wave says patent extends IP reach
9. `Single-sales factor extends tax treatment to tech, service firms
10. Alumni Association extends database help to university
11. Small-Tree extends G5 networking platform to G4, Windows and Linux
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... This is a professional and ... Isopropanol (IPA) industry. The report provides a basic ... industry chain structure. Global market analysis and Chinese ... on history, developments, trends and competitive landscape of ... Chinese situation is also offered. , The report ...
(Date:9/23/2014)... 23, 2014 Marktech Optoelectronics has introduced ... violet emitters in the 280 nm wavelength range. This ... which range from 280nm to 405nm. These new devices ... as well as curing. Mark Campito, Marktech’s CEO states ... interest to manufacturers is that we offer it in ...
(Date:9/22/2014)... treated with a statin in the hospital after suffering ... survive than those who were not, according to a ... study was conducted by the same researchers who recently ... survival in victims of ischemic stroke., Ischemic stroke is ... vessel that blocks blood from reaching areas of the ...
(Date:9/22/2014)... fragments whose job it is to stop bleeding, are ... they can "feel" the physical environment around them, researchers ... respond to surfaces with greater stiffness by increasing their ... platelets and other components of the clotting system, the ... them credit for, in that they are able to ...
Breaking Biology Technology:(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 2(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 3Marktech Introduces its New Line of Deep UV Emitters 2Statin use during hospitalization for hemorrhagic stroke associated with improved survival 2Platelets modulate clotting behavior by 'feeling' their surroundings 2
... - With Sony set to take over Sonic Foundrys desktop ... go from here? Two words: Mediasite Live. , ,Sonic ... audio conferencing market by enhancing web conferencing with Mediasite Live. ... great opportunity for the company to go forward because there ...
... stream video from their Charleston and Morgantown campuses so students ... All of WVUs core graduate nursing school courses will be ... ,We need more nurses and we need more nurse educators ... professor of nursing at WVU School of Nursing. By using ...
... better drugs, faster part of the speech. Thats where the ... is likely to hit the road, especially as the largest ... become as common in conversation as golf games and grandkids. ... Vodenlich joined as president earlier this year, recently restructured its ...
Cached Biology Technology:Sonic Foundry: What's Next? 2Sonic Foundry Facilitates Nursing Education 2Sonic Foundry Facilitates Nursing Education 3Chipping Away at Drug Development 2Chipping Away at Drug Development 3
(Date:9/23/2014)... years, man has domesticated animals, selecting the best ... sheep offer an intriguing animal to examine adaptation ... centuries of selected breeding and a wealth of ... first-of-its kind study that combined molecular and environmental ... search for genes under environmental selection from domesticated ...
(Date:9/23/2014)... oil sands tailings has just gotten a lot greener ... Alberta civil engineering professors that uses solar energy to ... of using UV lamps as a light source to ... tailings ponds, professors Mohamed Gamal El-Din and James Bolton ... energy source treats the wastewater just as efficiently but ...
(Date:9/23/2014)... A multidisciplinary team at the University of Wisconsin-Madison and ... more affordable way to screen for neural toxins, helping ... National Institutes of Health (NIH) announced today that the ... support to continue the promising work as part of ... will receive approximately $7 million over the three-year project. ...
Breaking Biology News(10 mins):Being sheepish about climate adaptation 2Solar energy-driven process could revolutionize oil sands tailings reclamation 2UW-Madison team developing 'tissue chip' to screen neurological toxins 2UW-Madison team developing 'tissue chip' to screen neurological toxins 3
... (OSCC) is responsible for nearly a quarter of all head ... of cancer death - largely due to the failure of ... New research published in BioMed Central,s open access journal ... predict which patients are at higher risk of OSCC recurrence. ...
... at the University of York and Hull York Medical ... the brain is affected by age. Working with ... in Plymouth, they have studied responses to stress in ... that under stressful conditions, such as neuro-degeneration, resulting high ...
... a key role in turning off disease? Researchers ... a biosensor they,ve created that measures membrane lipid levels may ... distinguished professor of chemistry, and his coworkers engineered a way ... lipid levels. Their findings are reported in Nature ...
Cached Biology News:Researchers study aging's effect on the brain 2New membrane lipid measuring technique may help fight disease 2
Puromycin resistance gene (pac), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
Plasmid expressing Zeocin resistance gene....
...
... template is designed to allow kanamycin/neomycin ... It combines a prokaryotic promoter (gb2) ... E.coli with a eukaryotic promoter (PGK) ... cells. The prokaryotic promoter gb2 is ...
Biology Products: